Drug safety : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

Drug safety : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

Bibliographic Details
Main Author: Crosse, Marcia
Corporate Authors: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, United States. Government Accountability Office
Format: Government Document eBook
Language:English
Published: [Washington, D.C.] : U.S. Govt. Accountability Office, [2007]
Series:Testimony ; GAO-08-224 T.
Subjects:
United States. > Food and Drug Administration > Rules and practice.
Drugs > Safety measures.
Drugs > Inspection.
Online Access:https://purl.fdlp.gov/GPO/LPS88548

Internet

https://purl.fdlp.gov/GPO/LPS88548

Available Online

Holdings details from Available Online
Call Number: GA 1.5/2:GAO-08-224 T
 
Call Number Status Get It
GA 1.5/2:GAO-08-224 T Available